Prestige Consumer Healthcare Inc. Stock
The Prestige Consumer Healthcare Inc. stock is trending slightly upwards today, with an increase of €0.40 (0.950%) compared to yesterday's price.
Currently there is a rather positive sentiment for Prestige Consumer Healthcare Inc. with 4 Buy predictions and 0 Sell predictions.
With a target price of 61 € there is a positive potential of 43.19% for Prestige Consumer Healthcare Inc. compared to the current price of 42.6 €.
Pros and Cons of Prestige Consumer Healthcare Inc. in the next few years
Pros
?
B****
?
S********** s********
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
M***** P*******
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Prestige Consumer Healthcare Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Prestige Consumer Healthcare Inc. | 0.950% | -2.232% | 2.817% | -21.081% | -18.131% | -19.633% | -13.267% |
| Apollo Medical Holdings, Inc. | 0.000% | 2.439% | -14.286% | 33.333% | 58.491% | -2.326% | -42.564% |
| Petmed Express Inc | -4.290% | -11.322% | -10.186% | -40.994% | -46.535% | -85.909% | -93.369% |
| Suzuken Co Ltd | -0.740% | 0.741% | -0.730% | 8.800% | -17.073% | 8.800% | 8.800% |
Comments
Prestige Consumer Healthcare (PBH) had its price target lowered by Canaccord Genuity Group Inc. from $86.00 to $72.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (PBH) had its price target lowered by Oppenheimer Holdings, Inc. from $77.00 to $65.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) had its price target lowered by analysts at Oppenheimer Holdings, Inc. from $82.00 to $72.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for PBH provided by MarketBeat